Patents Assigned to RAYDIANT OXIMETRY, INC.
  • Patent number: 11937925
    Abstract: Independent component analysis may be performed on a plurality of detected electronic signals to separate signals within the detected electronic signals that are contributed by different sources. Each of the plurality of detected electronic signals may be received from a separate detector and may correspond to a detected optical signal emanating from a pregnant mammal's abdomen and a fetus contained therein. The detected optical signals may correspond to light that is projected into the pregnant mammal's abdomen from a light source. The separated signals may be analyzed to determine a separated signal that corresponds to light incident upon the fetus, which may be analyzed to determine a fetal hemoglobin oxygen saturation level of the fetus. An indication of the fetal hemoglobin oxygen saturation level may then be provided to the user.
    Type: Grant
    Filed: July 20, 2022
    Date of Patent: March 26, 2024
    Assignee: Raydiant Oximetry, Inc.
    Inventors: Neil Padharia Ray, Mark Andrew Rosen, Adam Jacobs, Kenneth Holt
  • Patent number: 11596361
    Abstract: A plurality of sets of simulated optical inputs that is simulated to travel through an animal model of tissue, thereby generating simulated light transmission data, and corresponding oximetry vales may be used to train a simulated fetal oximetry model to predict, or calculate, oximetry values for subsequently received sets of simulated light transmission data. The simulated fetal oximetry model may be adapted to train an in vivo fetal oximetry model that may be configured to predict, or calculate, fetal oximetry values for subsequently received sets of light transmission data received from an in vivo study of a pregnant mammal and her fetus.
    Type: Grant
    Filed: May 27, 2022
    Date of Patent: March 7, 2023
    Assignee: Raydiant Oximetry, Inc.
    Inventors: Neil Padharia Ray, Jana Kainerstorfer, Adam Jacobs, Andrew Prescott
  • Patent number: 11419530
    Abstract: Independent component analysis may be performed on a plurality of detected electronic signals to separate signals within the detected electronic signals that are contributed by different sources. Each of the plurality of detected electronic signals may be received from a separate detector and may correspond to a detected optical signal emanating from a pregnant mammal's abdomen and a fetus contained therein. The detected optical signals may correspond to light that is projected into the pregnant mammal's abdomen from a light source. The separated signals may be analyzed to determine a separated signal that corresponds to light incident upon the fetus, which may be analyzed to determine a fetal hemoglobin oxygen saturation level of the fetus. An indication of the fetal hemoglobin oxygen saturation level may then be provided to the user.
    Type: Grant
    Filed: December 28, 2018
    Date of Patent: August 23, 2022
    Assignee: RAYDIANT OXIMETRY, INC.
    Inventors: Neil Padharia Ray, Mark Andrew Rosen, Adam Jacobs, Kenneth Holt
  • Patent number: 11375926
    Abstract: Light reflected from a pregnant woman's abdomen and fetus contained therein that has been received by a detector and converted into a reflected electronic signal may be received by a processor. A portion of the reflected electronic signal that is reflected from the fetus may be isolated and the isolated portion of the reflected electronic signal may be analyzed to determine a fetal hemoglobin oxygen saturation level of the fetus. The isolation may be achieved by synchronizing the reflected electronic signal with a fetal heartbeat signal and multiplying the synchronized reflected electronic signal by the synchronized fetal heartbeat signal.
    Type: Grant
    Filed: July 24, 2019
    Date of Patent: July 5, 2022
    Assignee: RAYDIANT OXIMETRY, INC.
    Inventor: Neil Padharia Ray
  • Patent number: 10987036
    Abstract: Fetal tissue oxygenation may be performed transabdominally by, for example, receiving a plurality of detected electronic signals that correspond to light emitted from a pregnant mammal's abdomen and a fetus contained therein that has been detected by the detector and converted into the detected electronic signal. An indication of a depth of the fetus within the pregnant mammal's abdomen may be received and a portion of the detected electronic signals that correspond to light that was incident upon the fetus may be isolated responsively to the indication of the depth of the fetus using, for example, time of flight of photons that correspond to the detected electronic signals. A fetal tissue oxygen saturation level may then be determined using the isolated portion of the detected electronic signals that correspond to light that was incident upon the fetus.
    Type: Grant
    Filed: June 25, 2020
    Date of Patent: April 27, 2021
    Assignee: RAYDIANT OXIMETRY, INC.
    Inventors: Neil Padharia Ray, Mark Andrew Rosen, Adam Jacobs, Denise Zarins, Kenneth Holt, Jana M Kainerstorfer, David Boas
  • Publication number: 20200352487
    Abstract: A system and/or device for transabdominal fetal oximetry and/or fetal pulse oximetry and/or uterine tone determination may include one or more articulating, adjustable, and/or selectable components such as a light source and/or a photodetector. In some embodiments, the positioning of a light source and/or detector may be adjustable. The articulation and/or adjustment of position of the light source and/or photodetector may be in any plane (X, Y, and/or Z) and, in some instances, may be responsive to a fetal position within a maternal abdomen. Light detected by the detectors may be used to determine a fetal hemoglobin oxygen saturation level and/or a muscular state (e.g., contracted or relaxed) of the pregnant mammal's uterus.
    Type: Application
    Filed: December 28, 2018
    Publication date: November 12, 2020
    Applicant: Raydiant Oximetry, Inc.
    Inventors: Neil Padharia RAY, Mark Andrew ROSEN, Adam JACOBS, Nevan HANUMARA
  • Patent number: 10362974
    Abstract: Light reflected from a pregnant woman's abdomen and fetus contained therein that has been received by a detector and converted into a reflected electronic signal may be received by a processor. A portion of the reflected electronic signal that is reflected from the fetus may be isolated and the isolated portion of the reflected electronic signal may be analyzed to determine a fetal hemoglobin oxygen saturation level of the fetus. The isolation may be achieved by synchronizing the reflected electronic signal with a fetal heartbeat signal and multiplying the synchronized reflected electronic signal by the synchronized fetal heartbeat signal.
    Type: Grant
    Filed: May 7, 2018
    Date of Patent: July 30, 2019
    Assignee: RAYDIANT OXIMETRY, INC.
    Inventor: Neil Padharia Ray
  • Patent number: 9757058
    Abstract: Light beams emitted from one or more light sources may be directed into an abdomen of a pregnant mammal toward a fetus contained therein. Some of the light may be reflected by the pregnant woman and fetus and received at a detector over a first time. A photo detector into an electronic reflected signal, which may be communicated to a computer, may then convert the received light. The electronic reflected signal may then be processed and/or analyzed to isolate a portion of the electronic reflected signal reflected from the fetus. The isolated portion of the electronic reflected signal reflected from the fetus may then be analyzed to determine a fetal hemoglobin oxygen saturation level of the fetus. An indication of the fetal hemoglobin oxygen saturation level may then be provided to an operator by way of, for example, a computer display.
    Type: Grant
    Filed: December 29, 2016
    Date of Patent: September 12, 2017
    Assignee: RAYDIANT OXIMETRY, INC.
    Inventor: Neil Padharia Ray